UNIGE document Scientific Article
previous document  unige:9383  next document
add to browser collection

Supersensitive Viral Load Assay in Predicting CD4-Guided Treatment Failure

Langford, Simone
Duncombe, Chris
Jupimai, Thidarat
Mahanontharit, Apicha
Kiertiburanakul, Sasisopin
Munsakul, Warangkana
Ruxrungtham, Kiat
show hidden authors show all authors [1 - 10]
Published in The Open Virology Journal. 2008, vol. 2, p. 69-73
Abstract In HIV patients who discontinue highly active antiretroviral therapy (HAART), the degree of HIV RNA suppression at the time of treatment interruption may predict success of re-treatment after the interruption (STI). A case-control substudy of the Staccato trial in Thailand included CD4-guided STI subjects with HIV RNA > 50 copies /ml (virological failure cases, n=11) and HIV RNA < 50 copies/ml (controls, n=22) after 12-24 weeks of HAART re-treatment following a median of 2 STI cycles. Controls were matched for age, gender and pre-ART CD4 count. HIV RNA with 5 copies/ml detection limit was determined on pre-virological failure samples. HIV RNA increased in cases compared to controls with each successive STI cycle (p-trend across time-points 0.004). The last HIV RNA below 50 copies/ml was significantly higher among cases compared to controls (p=.004). Measuring HIV RNA below 50 copies/ml may be useful in predicting virological failure to STI.
PMID: 19440466
Full text
Research group Epidémiologie clinique (115)
(ISO format)
LANGFORD, Simone et al. Supersensitive Viral Load Assay in Predicting CD4-Guided Treatment Failure. In: The Open Virology Journal, 2008, vol. 2, p. 69-73. doi: 10.2174/1874357900802010069 https://archive-ouverte.unige.ch/unige:9383

501 hits



Deposited on : 2010-07-12

Export document
Format :
Citation style :